What is Retatrutide?
Retatrutide is a triple glucagon, GIP, and receptor agonist. Retatrutide showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM).Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor .Retatrutide can be used for the research of obesity.Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual:Handling and Storage of Synthetic Peptides.Retatrutide is a new weight loss drug being experimented on by Eli Lilly, a pharmaceutical giant renowned for its breakthrough in diabetes and obesity treatment. Much like other weight loss drugs rolled out by Eli Lilly, Retatrutide is administered under the skin (subcutaneous route) per week and has yielded exceptional results in treating chronic diseases like diabetes and obesity compared to the predecessors.
-
Items
| Specifications |
| Product Name | Retatrutide |
| Form | Solid freeze-dried powder |
| Storage condition | -20°C |
| Purity | 99% |
| Packaging | Bottle, Can, Drum, Plastic Container, Vacuum Packet (According to customers' requirements) |
| Trademark | Customzied accepted |
Function and Mechanism of Action
1.Treatment of depression and anxiety disorders: Retatrutide has been shown to have antidepressant and anxiolytic effects in preclinical studies, suggesting that it could be a promising treatment option for individuals with these conditions.
2.Prevention of neurodegenerative diseases: Retatrutide has neuroprotective properties that may be useful in preventing or slowing the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
3.Enhancement of cognitive function: Retatrutide has been shown to improve learning and memory in animal studies, suggesting that it could have potential as a cognitive enhancer in humans.
4.Treatment of chronic pain: Retatrutide has been shown to have analgesic effects in preclinical studies, suggesting that it could be a useful treatment option for individuals with chronic pain conditions.
5.Promotion of wound healing: Retatrutide has been shown to accelerate wound healing in animal studies, suggesting that it could have potential as a therapeutic agent for promoting wound healing in humans.
1.Retatrutide is often used in the pharmaceutical industry, weight losing, etc.
2.Retatrutide is a kind of peptide product.
3.Retatrutide acetate can inhibited GCGR, GIPR and GLP-1R.
4.Retatrutide acetate is activated by glucagon receptors resulting in significant weight loss and increased energy expenditure.
5.Retatrutide acetate can be used in studies of obesity.
Hong Kong City Trade Co., Ltd. was established in 2019 and possesses strong R&D capabilities, excellent synthesis technology, and advanced quality control measures. We effectively collaborate with major companies and manufacturers, and serve society and a wide range of users based on the principles of industrial development. We consistently focus on market demand, continuously synthesizing new chemical products and pharmaceutical intermediates with high technological content, primarily exporting to the United States, India, South Africa, Nigeria, and many other countries and regions. We have extensive export experience to ensure safe transportation and guarantee that every customer receives their goods safely and promptly.
